Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Life Science Alliance
|
March 4, 2021
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
Elena A Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, et al.
Scientific Reports
|
July 15, 2021
MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells
Sofia Zanotti, Suzanne Vanhauwaert, Christophe Van Neste, et al.
Cancer Research
|
April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN
Chi Yan Ooi, Daniel R Carter, Bing Liu, et al.
Cancers
|
October 13, 2021
MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation
Jolien De Wyn, Mark W Zimmerman, Nina Weichert-Leahey, et al.
Genes, Chromosomes & Cancer
|
December 18, 2020
Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions
Liselot M Mus, Stéphane Van Haver, Mina Popovic, et al.
Oncogene
|
December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expression
Shana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Nature Communications
|
March 7, 2023
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
Bieke Decaesteker, Amber Louwagie, Siebe Loontiens, et al.
Nature Communications
|
November 20, 2018
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, et al.
Science Advances
|
July 20, 2022
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
Carolina Nunes, Lisa Depestel, Liselot Mus, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Life Science Alliance
|
March 4, 2021
Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
Elena A Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, et al.
Scientific Reports
|
July 15, 2021
MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells
Sofia Zanotti, Suzanne Vanhauwaert, Christophe Van Neste, et al.
Cancer Research
|
April 4, 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN
Chi Yan Ooi, Daniel R Carter, Bing Liu, et al.
Cancers
|
October 13, 2021
MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation
Jolien De Wyn, Mark W Zimmerman, Nina Weichert-Leahey, et al.
Genes, Chromosomes & Cancer
|
December 18, 2020
Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions
Liselot M Mus, Stéphane Van Haver, Mina Popovic, et al.
Oncogene
|
December 13, 2018
ALK positively regulates MYCN activity through repression of HBP1 expression
Shana Claeys, Geertrui Denecker, Kaat Durinck, et al.
Nature Communications
|
March 7, 2023
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
Bieke Decaesteker, Amber Louwagie, Siebe Loontiens, et al.
Nature Communications
|
November 20, 2018
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, et al.
Science Advances
|
July 20, 2022
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
Carolina Nunes, Lisa Depestel, Liselot Mus, et al.
Page
of 2